Garcinia Cambogia (HCA) for Liver injury and Garcinia Cambogia (HCA)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Garcinia Cambogia (HCA) for Liver injury
Evidence grade C — Rare but serious
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Garcinia Cambogia (HCA)
A perennial TV weight-loss star that fails in controlled trials — and carries a rare liver risk.
Grade D2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Garcinia Cambogia (HCA) for Liver injury | Garcinia Cambogia (HCA) |
|---|---|---|
| Liver injury | Evidence grade CSmall effectlowRare but serious | Evidence grade CSmall effectlowRare but serious |
Graded only in Garcinia Cambogia (HCA) for Liver injury
None — every outcome it grades is graded in both.
Graded only in Garcinia Cambogia (HCA)
- Weight loss Trivial effectEvidence grade D
What each entry says about the other
- Garcinia Cambogia (HCA) for Liver injury’s entry · Goes with: Read the full Garcinia Cambogia (HCA) monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.